Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2007
05/30/2007EP1790642A1 Biologically active methylene blue derivatives
05/30/2007EP1790641A1 Triazole derivative or salt thereof
05/30/2007EP1790353A1 Combined use of a GLP-1 compound and a modulator of diabetic late complications
05/30/2007EP1790352A1 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
05/30/2007EP1790346A2 Use of bile acid or bile salt fatty acid conjugates
05/30/2007EP1790340A2 Combination chemotherapy
05/30/2007EP1790339A1 Composition for prevention of occurrence of cardiovascular event
05/30/2007EP1790331A1 Use of pyridoxal-5-phosphate for the treatment of cardiovascular and related pathologies
05/30/2007EP1789407A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
05/30/2007EP1789056A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts
05/30/2007EP1789051A1 Endothelin a receptor (eta) antagonists in combination with phosphodiesterase 5 inhibitors (pde5) and uses thereof
05/30/2007EP1789047A2 Treatment of diseases using nalmefene and its analgos
05/30/2007EP1482858A4 Methods for aneurysm repair
05/30/2007EP1458672B1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha(ppar)
05/30/2007EP1373220B1 Benzimidazoles that are useful in treating sexual dysfunction
05/30/2007EP1318814B1 Triazole compounds useful as protein kinase inhibitors
05/30/2007EP1285655B1 Stabilized pharmaceutical compositions containing the calcium channel blocker azelnidipine
05/30/2007EP1272504B1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
05/30/2007EP1257537B1 Therapeutic morpholino-substituted compounds
05/30/2007EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/30/2007EP1180103B1 Renin inhibitors
05/30/2007EP1177168B1 Caspase inhibitors and the use thereof
05/30/2007EP1171165B1 Intramyocardial injection of autologous bone marrow
05/30/2007EP1107791B1 Hydrogel compositions for the controlled release administration of growth factors
05/30/2007EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders
05/30/2007CN1972944A Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
05/30/2007CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
05/30/2007CN1972931A Drug for treating or preventing duplication of hypertension with serum hyperuricemia and/or hypercholesterolemia
05/30/2007CN1972927A Compounds and methods for treating dyslipidemia
05/30/2007CN1972714A Methods of treating autoimmune and inflammatory diseases
05/30/2007CN1972701A Appetite-suppressing compositions and methods
05/30/2007CN1972679A Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists
05/30/2007CN1972665A Injectable depot compositions and uses thereof
05/30/2007CN1970746A Bifunctional variants of recombinant tissue-type plasminogen activator with platelet aggregation inhibitory activity
05/30/2007CN1970538A 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
05/30/2007CN1970529A Cardiovascular drug acebutolol intermediate 2- acetyl-4-n-butyramidophenol synthesis method
05/30/2007CN1970069A Chinese medicinal pill for treating coronary heart disease
05/30/2007CN1970066A Medicament for treating phlebitis of mammary gland
05/30/2007CN1970050A Pharmaceutical composition for treating arrhythmia and preparation process thereof
05/30/2007CN1970048A Chinese medicinal oral liquid for treating hypertension
05/30/2007CN1970043A Drop pill formulation of 'Mai Luo Ning' and preparation process thereof
05/30/2007CN1970040A Chinese medicine for treating hypertension, diabetes and coronary heart disease caused by atherosclerosis
05/30/2007CN1970035A Formulation of 'Sheng Mai', preparation process and quality control method thereof
05/30/2007CN1970015A Enzymatic extraction method of pawpaw polyphenol
05/30/2007CN1970009A Chinese medicinal suppository for treating piles quickly
05/30/2007CN1970008A Health tea capable of lowering blood pressure and decreasing blood fat and preparation process thereof
05/30/2007CN1970006A Chinese medicinal wine for treating piles and preparation process thereof
05/30/2007CN1970002A Method for preparing minipill of 'Xue Fu Zhu Yu'
05/30/2007CN1969980A Chinese medicinal formulation for treating angina pectoris and preparation process thereof
05/30/2007CN1969979A Injection having functions in activating blood circulation to remove stasis, unblocking collaterals to stop pain and method for preparing same
05/30/2007CN1969961A Medicinal granule for treating cerebral apoplexy and preparation process thereof
05/30/2007CN1969951A Novel extract of red sage root and dalbergia wood and preparation process thereof
05/30/2007CN1969940A Antivirus pharmaceutical composition
05/30/2007CN1969910A Drop pills containing panax notoginsenosides for treating cardiovascular and cerebrovascular disease and preparation process thereof
05/30/2007CN1969903A Acanthopanax extract medicament for preventing and treating cardiovascular and cerebrovascular disease and preparation process thereof
05/30/2007CN1969894A Medicament for treating cardiovascular and cerebrovascular diseases and preparation process thereof
05/30/2007CN1969893A Orally disintegrating tablet for treating cerebral apoplexy and preparation process thereof
05/30/2007CN1969885A Cap capable of preventing and treating cerebral haemorrhage
05/30/2007CN1969884A Medicament for treating piles
05/30/2007CN1969855A Pharmaceutical composition having target organ protection function and usage thereof
05/30/2007CN1969836A Ferulic acid and sodium ferulate preparation for inducing stem cell differentiating into nerve stem cell and pharmaceutical application thereof
05/30/2007CN1969833A Dry powder composition containing CoQ10 and preparation process thereof
05/30/2007CN1969822A Red sage root salvianolic acid A injection formulation for treating cardiovascular diseases and preparation process thereof
05/30/2007CN1318594C Recombinant human VEGF and bFGF eukaryon expression vector, fused protein and applications thereof
05/30/2007CN1318569C Method for preparing compound tea of ganoderma lucidum mycelium
05/30/2007CN1318561C Caterpillar fungus yellow rice wine
05/30/2007CN1318440C Preparation method of low-acid ginkgo leaf extract
05/30/2007CN1318439C Preparation method of amygdalin and its application in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound
05/30/2007CN1318435C Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
05/30/2007CN1318428C Thiophenopyridine substituted acetyl hyarazine derivative
05/30/2007CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics
05/30/2007CN1318416C Indazole amide compounds as 5-serotoninergic agents
05/30/2007CN1318412C Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
05/30/2007CN1318404C Aryl ureas as kinase inhibitors
05/30/2007CN1318403C Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
05/30/2007CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors
05/30/2007CN1318102C Medical devices containing rapamycin analogs
05/30/2007CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
05/30/2007CN1318084C Neuroprotective peptides
05/30/2007CN1318062C Composition containing extracts of pagodatree fruits, grape seeds and peel and preparation method thereof
05/30/2007CN1318047C Medicine for preventing and curing cardio cerebral vascular diseases and its preparing method
05/30/2007CN1318030C Methods and compositions useful in enhancing oxygen delivery to cells
05/30/2007CN1318026C Solid pharmaceutical formulations comprising modafinil
05/30/2007CN1317979C Modified methionine rich food products and process for their manufacture
05/29/2007WO2006034832A2 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions
05/29/2007US7223882 Reacting 2-amido-alkoxycarbonyl-benzaldehyde compound with alkoxycarbonyl-phosphonate compound, in the presence of lithium hydroxide in an organic solvent, adding lithium hydroxide adding an acid to the solution to obtain triterpene derivative
05/29/2007US7223867 Preparation of benzosuberonylpiperidine compounds
05/29/2007US7223866 Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases
05/29/2007US7223858 Truncated aggrecanase molecules
05/29/2007US7223846 Urocortin proteins and uses thereof
05/29/2007US7223839 Splice variants of the human H3 histamine receptor having deletions of portions of the N-terminal of the wild type H3 receptor; useful in methods for identifying agonists, inverse agonists or antagonists of histamine action at the H3 receptor; therapeutic and diagnostic agents; nervous system disorders
05/29/2007US7223835 Cyclic peptide mimetic for treating cancer; anticarcinogenic agents
05/29/2007US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation
05/29/2007US7223783 Indolinone derivatives
05/29/2007US7223781 Immunomoderators; autoimmune disease; drug, cosmetics; antiinflammatory agnets
05/29/2007US7223778 5-substituted-2-arylpyridines
05/29/2007US7223777 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
05/29/2007US7223772 Cyclooxygenase-2 inhibitors (COX-2); 4-[2-(3-fluoro-phenyl)-6-trifluoromethyl-pyrazolo[1,5-a]pyridin-3-yl]benzenesulfonamide for example; fever, pain, inflammation, neurodegenerative disorders, oral diseases, influenza, arthritis, allergies
05/29/2007US7223764 Antilipemic agents; anticholesterol agents
05/29/2007US7223763 Substituted sulfonamides and ureas useful for inhibiting kinase activity
1 ... 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 ... 1595